Matthias Evers (@matt_bigscience) header
Matthias Evers (@matt_bigscience) profile picture

Drug R&D fails at decisions, not ideas. Human data + AI to fix it. Writing "At the Decision Point" → https://nitter.gq/t.co/GxgycH4C6t | healthspanmaxing · mahjongg · 中文

Hamburg, Germany
Joined January 2009
Photo by Matthias Evers (@matt_bigscience)Photo by Matthias Evers (@matt_bigscience)Photo by Matthias Evers (@matt_bigscience)Photo by Matthias Evers (@matt_bigscience)Photo by Matthias Evers (@matt_bigscience)Photo by Matthias Evers (@matt_bigscience)Photo by Matthias Evers (@matt_bigscience)Photo by Matthias Evers (@matt_bigscience)
Well said - contrast this with posts we see in Germany from politicians on this.
I’ve spent a few days thinking about the Tesla Roadster reveal and landed somewhere I haven’t seen much discussion. I’m neither a Tesla fanboy nor a Tesla hater. And I couldn’t care less whether what we saw technically qualifies as a flying car. Three takeaways: (1) The risk of that live demonstration going horribly wrong was real. Almost no CEO would willingly expose their company to that kind of public humiliation for a product with so little financial upside. Elon did. (2) That willingness to attempt the seemingly impossible is what makes Tesla special. It’s also arguably Elon’s greatest contribution to America. He’s helped bring back something we’ve lost. The American spirit of chasing big scary ideas that most people think are impossible. That mindset is spreading across a new generation of founders and its long term impact on America’s future could dwarf anything Tesla ever sells. I think this is deeply underappreciated. (3) Can we just acknowledge how insanely cool that moment was? We’ve reached a strange place culturally where even extraordinary feats of human ingenuity immediately become arguments about why they don’t count. Not everything needs to be a debate. Sometimes we should just be able to stand back together and marvel at what humans are capable of. I’ve been both bullish and critical of Tesla’s ambitions over the years. But watching Elon and his team push the boundaries of what’s possible reminds me why I’m glad we have him. Whether the Roadster ever makes Tesla a dollar or impacts $TSLA stock price is almost beside the point. We need more people willing to risk failure in pursuit of things the rest of us think are impossible. Because when they succeed we all win.
84
Matthias Evers retweeted
“If you don’t have a vision about what you want to do, if you don’t have a plan about what you want to do, if you don’t act on it every day, it’s not going to happen. It’s just not going to happen.“ — Tim McGraw Listen to this special compilation episode on turning failure into success, featuring Terry Crews, Tim McGraw, Jessica Lahey, Dax Shepard, BJ Miller, Cathy Lanier, Janna Levin, and Boyd Varty: tim.blog/2026/09/04/failure-…
16
48
3
389
76,138
Second essay of At the Decision Point. The Right to Stop: the clause that makes continuing the decision. elbbridge.com
57
The 1000x framing quietly licenses waiting, and that is the expensive part. Quantity is half the answer at most. A small, deeply paired, well controlled cohort answers questions now that a petabyte of more of the same will still not answer. Depth can be generated today.
While data quantity is a problem, it may not be the most dire. Data diversity, lack of data pairing (across modalities and scales), and inadequate measurement technologies are biology’s biggest hurdles for AI. Scaling up the same type of data that exists isn’t the solution.
168
Here we must go.
2005: first human gene edit. For a gene mutated in pediatric immune disease. 2026: 50,000 papers on gene editing, zero trials in such disease. This ARPA-H funding is to change that: 1. CRISPR nonviral in vivo 2. 10 patients 3. Platform mode Here we go. innovativegenomics.org/news/…
131
All "small" examples, perhaps? Wonder how we look back at this time in a few years. More like "this is when the [positive] magic happened" or more like going back to Skynet.
one of the craziest things i’ve read in uhhhh…. *checks notes* 3 days. welcome to the singularity i guess 07/21/26 — Codex escapes eval and attacks Hugging Face 07/20/26 — Jacobian counterexample 05/20/26 — Unit-distance conjecture 04/14/26 — Erdős #1196 primitive sets 04/07/26 — Glasswing finds tons of zero-days
104
Matthias Evers retweeted
Thymulin, the peptide derived from the thymus, suppresses age-related inflammaging and, in the experimental model, helps protect vs cancer nature.com/articles/s41467-0…
21
181
22
802
154,332
Six mega rounds in China, zero antibodies. Thank you @chuminhua432
2026 H1 China private biotech financing tracker nitter.gq/chuminhua432/status/20… 🔹Private Chinese biotech companies raised more than $3.49 billion across at least 115 deals in H1 2026 — already surpassing all of full-year 2024 financing and nearly triple last year's first-half total. 🔹State-backed funds led nearly a third (32%) of these rounds. 🔹Six "mega-rounds" worth over $100 million each — none involving antibody drugs — accounted for close to a third (31%) of all capital raised. 🔹The boom is highly concentrated: rounds of $50 million or more made up just 15.5% of deals but captured 56% of total funding, while many early-stage startups still can't secure enough cash to advance a single asset into the clinic. 🔹Investors have grown more conservative on disease areas, favoring oncology and metabolic disease, even as they've become bolder on modality, pouring money into cell therapy and radiopharmaceuticals. 🔹Hong Kong IPOs are rebounding sharply and Shanghai's STAR Market may reopen to biotech listings after a three-year freeze — though both venues remain difficult for early-stage, pre-profit companies, pushing more Chinese innovation toward the "NewCo" model of licensing assets into US-based startups instead.
1
97
Europe is planning 5 AI gigafactories. €20bn, sites still being selected. China Telecom, one telco, reports 900+ data centers already built and power capacity approaching 8 GW. Roughly the EU's entire installed base. The gap isn't ambition. It's clock speed.
China Telecom says its 息壤 compute platform now manages > 100 EFLOPS of compute. It has > 900 data center w/ total power capacity approaching 8 GW. It's currently exploring OCS all-optical networking inside compute clusters to support ultra-large scale cluster. Also investing in submarine cables & 800G fiber network development to continue building up reliable domestic network
102
Matthias Evers retweeted
Michael Phelps won 23 Olympic gold medals using a mental technique most athletes ignore: "The biggest thing that really separated me through my career was my mental game. Everything that was in between my ears." Michael explains how he used visualization: "When I would visualize, I'd visualize every single thing getting up to a meet, probably a month or so in advance. What could happen. What I want to happen. And what I don't want to happen. Because when it happened, I was prepared for it." He describes the goal: "When I got to a swim meet, there's nothing I can control at that point except what I do. I can't control what anybody else does. So I want to know how the race could go, how I don't want the race to go, and in a perfect world, how the race should go. So I could get behind the block and not have to think about anything." His coach Bob Bowman reveals how they trained this skill: "When Michael was young, I gave his mom a book of progressive relaxation. Before he'd go to bed at night, she would read this progression of things: clench your fists, work through your whole body. He got so good she'd just open the book, say two things, and he'd be asleep." Bowman explains why visualization works: "The brain cannot distinguish between something that's vividly visualized and something that's real. By the time Michael steps up on the block at the Olympics, he's swum that race hundreds of times in his mind. All he has to do is shut everything down and it goes on autopilot." Michael adds the key detail most miss: "When I would visualize, it would be what you want it to be, what you don't want it to be, what it could be. So you're always ready for anything. If I have a suit rip, fine, I need another suit, put it on. Any small thing that could go wrong, I'm ready for."
15
273
10
1,234
142,757
3 years ago, we laid out a bold vision for biopharma R&D: understand disease in humans + combine human & machine intelligence to discover better therapies. With today’s AI momentum, this isn’t just a vision—it’s a roadmap. I’m all in. 🧠🤖
1
1
1
165
Congrats. @zavaindar & Team!
Today we're unveiling Dimension II: a $500M fund to support and partner with the leading builders at the vanguard of life sciences and technology. To our entrepreneurs, past present and future: Our work is far from done. LFG.
2
238
Imagine the last five years without this. reddit.com/gallery/1h5ggou
58
Being in there for the mission and the fun of it.
Sam Altman reconfirms that he has ZERO equity in OpenAI
1
1
233
It's launch day ... with PanHunter from patient-driven disease understanding to new therapies. evotec.com/en/investor-relat…
1
AI has made great strides in recent years, enabling the processing of large amounts of data in a short time frame. In this publication Evotec experts review state-of-the-art #AI methods being applied to #drugdiscovery. - hubs.ly/Q019CfLM0 #researchneverstops
2
4